Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FQ67T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,066
Award facts
- Contract value 100% obligated
- $3,065.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens in 0.5 mL single-dose units, valued at $3,065.58. This competitive award represents a firm fixed price delivery order with an ultimate completion date of October 20, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, leverages its comprehensive portfolio to fulfill DLA's pharmaceutical supply requirements across multiple therapeutic domains. The DLA Troop Support Medical IDC serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards. This delivery order reflects AmerisourceBergen's capability to meet federal procurement standards through open competition and deliver specialized pharmaceutical products within expedited timeframes to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FQ67T?
SPE2DB26FQ67T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FQ67T worth?
The government has obligated $3,066 on SPE2DB26FQ67T.
Is contract SPE2DB26FQ67T an order under another contract?
Yes. SPE2DB26FQ67T is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ67T competed?
The extent of competition for SPE2DB26FQ67T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award